Key result
Gadolinium-based contrast is linked to nephrogenic systemic fibrosis and should be avoided in advanced renal failure.
Why the study?
Nephrogenic systemic fibrosis is a newly recognized disorder occurring exclusively in patients with renal failure and is associated with exposure to gadolinium-based magnetic resonance contrast media.
Answers are grounded in this paper and cite their sources.
Gadolinium-based MR contrast agents are associated with fatal nephrogenic systemic fibrosis in patients with renal failure and should be avoided when eGFR is below 30 ml/min/1.73 m2 unless essential.
Nephrogenic systemic fibrosis (NSF) is a newly recognized disorder occurring exclusively in patients with renal failure. Exposure to gadolinium-based magnetic resonance (MR) contrast media has been associated with subsequent development of NSF. Nephrogenic systemic fibrosis is characterized by skin induration preferentially affecting the extremities. In addition, involvement of internal organs occurs, which leads ultimately to death. Skin biopsy is important for confirmation of the diagnosis. The main therapeutic goal is restoration of renal function. To reduce the risk of NSF, renal function must be determined before exposure to gadolinium-containing MR contrast agents. Gadolinium-based MR contrast media should be avoided in the presence of advanced renal failure with estimated glomerular filtration rate below 30 ml/min/1.73 m2, unless the diagnostic information is essential and not available with noncontrast magnetic resonance imaging techniques. The recommended dose of contrast agent should not be exceeded. In addition, a sufficient period of time for elimination of the contrast agent from the body should be allowed before readministration of the contrast agent.
No takes yet. Share an insight, caveat, or question.
Kribben et al. (2009) conducted a review in Nephrogenic systemic fibrosis (NSF) in patients with renal failure. Gadolinium-based magnetic resonance contrast media was evaluated on Nephrogenic systemic fibrosis (NSF). Gadolinium-based MR contrast media is associated with nephrogenic systemic fibrosis and should be avoided in patients with advanced renal failure.
Synapse has enriched 10 related papers. Consider them for comparative context: